Manufacturing
We have State-of-the-Art manufacturing facility with WHO-GMP accreditation and US-FDA, UK-MHRA & ANVISA compliance. The Ahmedabad facility enable us to accelerate our growth in existing markets and also explore our wings globally.
We have ensured world-class quality in design, equipment and operations in our manufacturing facility, which enable us to provide best-in-class products at affordable prices to the patients across the globe.
Our manufacturing operations are focused on producing generics, branded generics, speciality, over-the-counter (OTC) products in the full range of dosage forms i.e. Tablets, Capsules, Oral Liquids & Dry syrups, Injections, Creams & Ointments etc.
Our Global Reach
Latest News
CPHI Milan
Oct-2024
UDAAN
Jan - 2021
Under the UDAAN initiative, from last three years, we have organized many cultural activities for BioMatrixians with their families. This gives us opportunity to strengthen team bonding.
EFDA, Ethiopia
July - 2022
Our state-of-the-art manufacturing facility has been approved by EFDA, Ethiopia for Oral solid, Liquid and dry powder dosage formulations.
NDA,Uganda
Aug - 2022
It is an indeed proud moment for Biomatrix to achieve another successive approval for Oral solid, dry powder and liquid dosage formulation. With this continuous accreditation, we strive to develop world-class products and make them available worldwide.
Three Star Export House
OCT - 2023
This is a proud moment for us that we have been accorded the status of THREE STAR EXPORT HOUSE by the Directorate General of Foreign Trade in honour of our extraordinary export performance and significant contributions to the country's economy. We are incredibly proud of "Team BioMatrix" for achieving this significant milestone.
EU-GMP Approval
Aug-2024
